Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves first CIRM‑funded gene‑editing therapy for rare immune disorder
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I in children without a matching bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine (CIRM), highlighting the agency’s impact on translational research.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
The FDA has released two public lists identifying registrants that failed to submit required drug amount reports for calendar year 2024. One list covers entities with active drug listings, the other captures those with inactive listings. Registrants must certify or update their listings twice a year—in June and December—and annually confirm no changes. The agency provides links to the PDFs and instructions, and offers a contact email for questions.
The FDA’s Adverse Event Monitoring System (AEMS) released a slate of new safety signals for a range of products covering October‑December 2025. Alerts include heightened hypersensitivity reactions for certain lots of Alyglo, hypogammaglobulinemia linked to multiple bispecific T‑cell engager therapies,...
Novo Nordisk introduced multi‑month subscription plans for its Wegovy obesity treatments, offering three, six or twelve‑month options for both the injectable and the high‑dose oral pill. The tiered pricing lowers monthly costs, delivering up to $1,200 in annual savings on...
The Gary-rule helps decide whether it is a health IT or a digital health issue. If a technological issue comes up in a healthcare setting, such as the antivirus software becomes outdated or the electronic medical record system stopped working...
Colorado-based Canyon Home Care & Hospice announced the acquisition of Columbine Poudre Home Care and its affiliate Bloom at Home, extending its service footprint across northern Colorado. The deal, whose financial terms were not disclosed, brings together two culturally aligned...
NVIDIA has assembled a comprehensive AI infrastructure stack for healthcare, encompassing BioNeMo, MONAI, Isaac for Healthcare, Holoscan, Parabricks, Clara and NIM. Its 2026 State of AI in Healthcare survey shows 70% of organizations actively using AI, with generative models now...
As a medical school professor, I've long suspected that Alzheimer's disease is metabolic at its core. Now we have clinical proof. A Wake Forest trial tested empagliflozin -- a common diabetes drug -- in NON-DIABETIC Alzheimer's patients for the first time. The...
A recent case study of a 55‑year‑old Ironman who suffered cardiac arrest revealed that his standard cholesterol test missed dangerously high levels of small dense LDL particles. The authors argue that advanced lipid testing could uncover hidden atherosclerotic risk in...
Pharma executives face accelerating market pressure, prompting a shift from static launch plans to agile, data‑driven execution. Remco op den Kelder of Inizio Ignite argues that real‑time insights, AI integration, and cross‑functional collaboration are essential for successful product launches over...
Brazil’s Organizações Sociais de Saúde (OSS) model transfers management of public hospitals to private non‑profit operators while keeping public ownership and funding. Using a difference‑in‑differences analysis of all hospitalisations from 2006‑2022, the study finds admissions up about 40%, bed turnover...
The article charts the transition of pharmaceutical 3D printing from research pilots to routine pharmacy practice, focusing on pediatric compounding. Companies such as FabRx and CurifyLabs have built platforms that let pharmacists print chewable tablets, gels, and mini‑tablets tailored to...
Novo Nordisk introduced a subscription service for its obesity treatment Wegovy, allowing cash‑pay patients to lock in three‑month, six‑month or twelve‑month supplies. The model promises lower out‑of‑pocket costs compared with traditional pay‑per‑dose purchases. By bundling shots and oral pills, Novo...
The Health Innovation Network’s webinar highlights France as a prime destination for UK digital health innovators, citing its universal health system, robust national digital health strategy, and permanent reimbursement pathways. Recent reforms such as Ma Santé 2022 and the €2 billion Ségur...
HealthTechX Asia highlights Singapore as a prime yet demanding market for UK health innovators, driven by a rapidly aging population and a government‑backed push for preventive, home‑based care. The article outlines three critical considerations: demographic shifts increasing demand for remote...
Constrictive pericarditis (CP) remains one of the most diagnostically challenging cardiac disorders. While most clinicians recognize the septal bounce on echocardiography, few appreciate the tissue Doppler and annular velocity signatures that reliably separate CP from restrictive cardiomyopathy. The post offers...
Blackstone announced the final close of its Life Sciences VI fund at a hard cap of $6.3 billion, roughly 40% larger than the prior vehicle. The BXLS platform, launched in 2018, now manages about $15 billion and invests across the entire drug...
Policy advisor Charlie Chapman, who counseled Health and Human Services Secretary Robert F. Kennedy Jr. on Medicare and Medicaid issues, has joined BGR’s health and life‑sciences practice as a vice‑president. Chapman previously coordinated DHHS actions with the White House and...
UCB’s Kygevi, a combination of doxecitine and doxribtimine, received its first EU approval for treating thymidine kinase 2 deficiency (TK2d) under exceptional circumstances. The drug, aimed at patients whose disease began before age 12, cut mortality risk by 95% compared with...
PepGen reported that its Phase 2 trial of an oligonucleotide therapy for a rare genetic nerve‑muscle disorder failed to meet its primary efficacy endpoints. The data showed no statistically significant improvement in muscle strength across the cohort, and one participant experienced...
The NHS Shared Business Services (SBS) now runs a national finance and procurement platform on Oracle Fusion Cloud, covering 48 NHS organisations and processing roughly $444 bn in transactions each year. The go‑live on 1 October 2025 handled $23.75 bn on day one and...
I did a futures wheel exercise with the Hungarian National Ambulance Service about an exciting possible milestone in the future: the ambulance fleet of a national service becoming fully autonomous by 2035. This exercise helps determine the primary and secondary consequences...
Blepharoplasty patients in Austin receive five practical after‑care tips to optimize healing and preserve results. Managing swelling with gentle cold compresses and an elevated sleeping position curbs fluid buildup in the first days. Strict adherence to the surgeon’s cleaning, medication...
Kimberly Smith, ViiV Healthcare’s Chief Scientific Officer, is retiring after more than three decades in HIV care, including 13 years leading the company’s R&D division. Smith’s tenure saw the launch of several next‑generation antiretroviral therapies and the expansion of ViiV’s...
A recent discussion among physicians highlights how low Medicare reimbursement for lumbar punctures (LPs) makes the procedure financially unsustainable in outpatient clinics. Medicare pays about $135 per LP while clinics incur roughly $194, prompting many doctors to refer patients to...
Eli Lilly announced a $6.3 billion acquisition of Centessa Pharmaceuticals, marking its largest deal in years. The purchase secures Centessa’s orexin‑based insomnia candidate and a pipeline of early‑stage neurological programs. Lilly is channeling cash generated by its GLP‑1 blockbuster drugs into the...
Alltrna, a biotech startup focused on transfer RNA (tRNA) therapeutics, has secured regulatory clearance to launch its first human clinical trial. The trial will evaluate a novel tRNA‑based drug designed to correct protein synthesis errors that underlie a range of...
Enveda Biosciences released its first clinical readout for an investigational atopic dermatitis therapy, showing efficacy comparable to AbbVie's Dupixent. The Phase 1 trial met its primary endpoints, demonstrating significant skin clearance and a safety profile similar to existing biologics. The...
Certificate‑of‑need (CON) regulations still govern health‑care entry in 35 states, requiring providers to prove community demand before building or expanding facilities. While originally justified in the 1970s to curb excess capacity and control costs, the system now enables incumbents to...
The Union Ayush Ministry has launched a government‑backed "Yoga Protocol for Non‑Communicable Diseases (NCDs) and Target Groups" across schools, workplaces and health centres. The disease‑specific modules prescribe 30‑60 minutes of daily asanas, breathing and meditation, aiming to address conditions that...
The UK government reports that the number of employers participating in the Keep Britain Working ‘vanguard’ programme has more than doubled, rising from 60 to 150 since the review’s launch in November 2025. These 150 organisations now represent roughly 1.5 million...
Two peer‑reviewed studies released this week reshape how depression is treated. Psychologists found that describing depression as a functional signal, not a brain defect, improves patients' expectations and reduces perceived chronicity. Meanwhile, Japanese neuroscientists identified the enzyme NOX‑1 as an...
The American College of Cardiology, American Heart Association and nine partner societies issued a sweeping update to the 2018 cholesterol guidelines, introducing a 30‑year risk calculator, stricter LDL cholesterol targets and earlier screening for children. The changes aim to curb...
A federal report shows 21% of U.S. births in 2023 were to women aged 35 or older, more than double the 1990 share. Obstetricians and maternal‑fetal specialists warn of higher complication rates but say targeted health measures can keep outcomes...
A large‑scale Swedish study of more than one million fathers reveals that about one in ten experience postpartum depression, with diagnoses spiking 30% toward the end of the first year after a child’s birth. Researchers say the delayed rise challenges...
A randomized trial of 958 adults aged around 70 found that two years of daily multivitamin–multimineral supplementation reduced the yearly rise of two epigenetic clocks by 2.6 and 1.4 months respectively. The modest effect, published in Nature Medicine, fuels debate...
Luye Pharma Group Ltd announced full‑year revenue of RMB6.308 bn ($883 m), a 4.1% rise from the prior year, and net earnings of RMB618.75 m ($86.6 m), up 31%. The results highlight robust domestic demand for its generic and specialty drugs amid a recovering...
Treasury Secretary Scott Bessent announced a new whistleblower platform that will pay informants 10‑30% of fines recovered from Medicare and Medicaid fraud, targeting an estimated $70 billion in annual abuse. The program mirrors the IRS’s whistleblower scheme, directs payouts from penalties,...
When enhanced premium tax credits lapsed, Florida's ACA marketplace members saw monthly premiums climb from $0.18 to $142, leaving patients like Kellie Brvenik to choose between life‑saving care and everyday expenses. The surge highlights the fragility of the individual market...
RenovoRx announced a widened FY25 net loss of $11.2 million, despite its first full year of revenue from the FDA‑cleared RenovoCath device. The company also outlined a timeline to complete enrollment for its Phase III TIGeR‑PaC oncology trial by mid‑2026, a move...
Scientists at the University of Michigan have demonstrated that protein‑coated nanoparticles can efficiently deliver DNA and mRNA to liver cancer, kidney and immune cells in vitro, marking a potential shift away from viral vectors in gene therapy. The platform uses...
Galapagos NV and Gilead Sciences have signed a binding framework agreement that gives Galapagos a 50% share of the $1.675 billion upfront consideration for Gilead’s acquisition of Ouro Medicines. The deal also locks in a $500 million cash pool for Galapagos, including...
Soley Therapeutics’ co‑founder and CEO Dr. Yerem Yeghiazarians explained the company’s novel strategy of using small‑molecule drugs to reverse cellular stress rather than targeting a specific virus or gene. The platform aims to restore function in stressed cells implicated in non‑oncology...
AstraZeneca’s Alexion unit intends to file a new long‑acting enzyme replacement therapy, efzimfotase alfa, as a successor to its Strensiq (asfotase alfa) for hypophosphatasia (HPP). Phase 3 data showed the drug met primary endpoints in pediatric patients but failed to achieve...
In this episode of American Sunrise, Dr. Peter McCullough critiques recent attempts by Robert F. Kennedy Jr. and the CDC to reduce the U.S. childhood vaccine schedule, arguing that the process excluded major medical societies and was therefore legally vulnerable. He contends that the...
India’s Union Budget raised the health ministry’s allocation by 10% to over Rs 1.06 lakh crore—approximately $13 billion—signalling a major fiscal push for the sector. The plan earmarks training for 100,000 allied‑health professionals and 150,000 caregivers over the next five years. Funding will also...
Harvard researchers uncovered that post‑natal skin scarring is driven by fibroblast‑produced Cxcl12, which triggers excessive nerve growth that blocks full tissue regeneration. By deleting Cxcl12 or applying Botox to suppress local nerve signaling, mice healed wounds without scars, restoring all...
In August, the Trump administration ordered states to re‑verify Medicaid enrollment for individuals whose immigration status was unclear. Five states that reported back found only a handful of undocumented enrollees were removed, with Pennsylvania and Colorado terminating none, Texas 77,...
The State Department has transferred only about $640 million of the $4.6 billion PEPFAR budget to the CDC, leaving a roughly $660 million shortfall for the fiscal year. The Trump administration’s shift from USAID to a CDC‑led model and its new memorandum‑of‑understanding (MOU)...
A systematic review and meta‑analysis of 15 randomized trials involving 644 patients and 742 implants examined low‑level laser therapy (LLLT) and antimicrobial photodynamic therapy (aPDT) as adjuncts to non‑surgical debridement for peri‑implantitis. The analysis found modest but statistically significant reductions...
A pre‑print study compared capillary dried blood spot (DBS) microsampling—including filter‑paper punches and Mitra volumetric absorptive microsamplers—with venous plasma for multiplex serosurveillance of seven vaccine‑preventable diseases. The analysis showed strong agreement for six pathogens, with ≥93% of paired measurements within...
